FILE PHOTO: Phial labelled "Sputnik V coronavirus disease (COVID-19) vaccine", March 24, 2021. REUTERS / Dado Ruvic/File Photo
MOSCOW/BRASILIA (Reuters) - The Russian developer of the Sputnik V coronavirus vaccine said on Thursday it would sue the Brazilian health regulator Anvisa for defamation, prompting a stern rebuttal from the agency.
Anvisa's board on Monday denied requests by Brazilian states to approve Sputnik V for import. The agency's manager for medicines and biological products, Gustavo Mendes, said there was evidence an adenovirus used in the vaccine could reproduce, which he called a "serious" defect.
Already a subscriber? Log in.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
